Dividend increase puts Encompass Health in focus

Encompass Health (EHC) has drawn fresh attention after lifting its quarterly dividend to US$0.21 per share, with payment scheduled for October 15, 2026, and an ex dividend date of October 1.

Despite the dividend headline, Encompass Health’s recent share price return has been mixed, with the stock down over the past week but posting a positive 90 day share price return and strong multi year total shareholder returns that point to momentum built over a longer horizon.

If this dividend move has you thinking about where else income and growth stories could come from in healthcare, it may be worth checking out 41 healthcare AI stocks

Encompass Health now trades at a sizeable discount to both intrinsic estimates and analyst targets, even after the dividend lift. Is this simply market caution about execution and costs, or a valuation gap that stands out?

Most Popular Narrative: 21.4% Undervalued

At a last close of $110.50, the most followed narrative on Encompass Health points to a fair value of $140.50, which implies a sizeable valuation gap based on analyst assumptions and a 7.11% discount rate.

The surge in the 65 plus population and persistent undersupply of inpatient rehabilitation beds are driving high and still unmet demand for Encompass Health's core services, ongoing hospital openings and bed expansions position the company to capture significant incremental patient volume, supporting higher revenue growth for years to come.

Curious what sits behind that fair value for Encompass Health? The narrative leans on steady revenue expansion, firmer margins, and a future earnings multiple that needs to hold up. The exact mix of growth, profitability and required valuation is all laid out in one place.

Result: Fair Value of $140.50 (UNDERVALUED)

However, the Encompass Health narrative also leans on continued demand for new hospitals while facing ongoing labor shortages that could put pressure on costs and margins.

Next Steps

If the mix of risks and rewards around Encompass Health feels finely balanced, now is a good time to review the details yourself and decide how it fits your portfolio. To get a clearer picture of both sides of the story, take a look at the 4 key rewards and 1 important warning sign

Looking for more investment ideas beyond Encompass Health?

Do not stop with Encompass Health. Use the Simply Wall St screener to spot clear opportunities, compare fundamentals quickly, and keep your watchlist stocked with fresh ideas.

• Hunt for potential growth stories at accessible prices by reviewing 20 elite penny stocks with strong financials.
• Focus on quality at a discount by scanning the 52 high quality undervalued stocks.
• Prioritise resilience and capital protection by checking the 82 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.